Pathogenesis and management of postprandial hyperglycemia: role of incretin-based therapies

Pathogenesis and management of postprandial hyperglycemia: role of incretin-based therapies

John Gerich Department of Medicine, Endocrine/Metabolism Division, University of Rochester School of Medicine, Rochester, NY, USA Abstract: Postprandial plasma glucose concentrations are an important contributor to glycemic control. There is evidence suggesting that postprandial hyperglycemia may be...

Full description

Bibliographic Details
Main Author:	Gerich J
Format:	Article
Language:	English
Published:	Dove Medical Press 2013-12-01
Series:	International Journal of General Medicine
Online Access:	http://www.dovepress.com/pathogenesis-and-management-of-postprandial-hyperglycemia-role-of-incr-a15174

Similar Items

Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk
by: Ajikumar V Aryangat, et al.
Published: (2010-03-01)

Role of incretins in the pathogenesis of type 2 diabetes
by: Radojčin Dragan, et al.
Published: (2018-01-01)

Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins
by: Koska Juraj, et al.
Published: (2011-07-01)

Role of Fluid Milk in Attenuating Postprandial Hyperglycemia and Hypertriglyceridemia
by: Miriam Leary, et al.
Published: (2020-12-01)

Postprandial hyperglycemia: a new frontier in diabetes management?
by: Ada Maffettone, et al.
Published: (2018-06-01)

Postprandial hyperglycemia as an etiological factor in vascular failure
by: Inoue Teruo, et al.
Published: (2009-04-01)

Incretin-based therapy: renal effects
by: Anton Ivanovich Korbut, et al.
Published: (2016-01-01)

Recent advances in incretin-based therapies.
by: Russell-Jones, D, et al.
Published: (2012)

Role of incretin based therapies in the treatment of diabetic kidney disease
by: Paola Fioretto, et al.
Published: (2018-11-01)

The Role of Hyperglycemia in Endometrial Cancer Pathogenesis
by: Frances L. Byrne, et al.
Published: (2020-05-01)

Fasting and Postprandial Hyperglycemia: Their Predictors and Contributions to Overall Hyperglycemia in Korean Patients with Type 2 Diabetes
by: Jaecheol Moon, et al.
Published: (2020-06-01)

Postprandial glucose, insulin and incretin responses differ by test meal macronutrient ingestion sequence (pattern study)
by: Sun, Lijuan, et al.
Published: (2020)

Role of incretin‐based therapy in hospitalized patients with type 2 diabetes
by: Abraham Edgar Gracia‐Ramos
Published: (2020-03-01)

Prevention of Postprandial Hyperglycemia by Ophthalmic Nanoparticles Based on Protamine Zinc Insulin in the Rabbit
by: Saori Deguchi, et al.
Published: (2021-03-01)

The role of incretin-based therapies in the management of type 2 diabetes mellitus: perspectives on the past, present and future
by: Juris J. Meier
Published: (2019-12-01)

Interactions between Intestinal Homeostasis and NAD<sup>+</sup> Biology in Regulating Incretin Production and Postprandial Glucose Metabolism
by: Taichi Nagahisa, et al.
Published: (2023-03-01)

Postprandial Hyperglycemia as a Significant Risk Factor for Coronary Heart Disease
by: Khalid I. Al-Lehibi, et al.
Published: (2011-12-01)

Incretins in the Therapy of Diabetic Kidney Disease
by: Agnieszka Przezak, et al.
Published: (2021-11-01)

Postprandial hyperglycemia and cardiovascular events. Acarbose therapy in patients with coronary heart disease and impaired carbohydrate metabolism
by: N. A. Logunova, et al.
Published: (2008-10-01)

Effects of Incretin-Based Therapies on Diabetic Microvascular Complications
by: Yu Mi Kang, et al.
Published: (2017-09-01)

Binding Interaction of Betulinic Acid to α-Glucosidase and Its Alleviation on Postprandial Hyperglycemia
by: Shaodan Chen, et al.
Published: (2022-04-01)

A phlorotannin constituent of Ecklonia cava alleviates postprandial hyperglycemia in diabetic mice
by: Hyun-Ah Lee, et al.
Published: (2017-01-01)

Effects of reducing postprandial hyperglycemia and metabolism of acetate wheat starch on healthy mice
by: Nguyen Van Thanh Toan, et al.
Published: (2022-04-01)

New glance at pathogenesis of type 2 diabetes mellitus: incretin and antiincretin systems.
by: Ekaterina Alekseevna Shestakova
Published: (2011-09-01)

Inflammation and Incretins
by: Amitabh Hatwal
Published: (2012-01-01)

Differentiating among incretin-based therapies in the management of patients with type 2 diabetes mellitus
by: Cobble Michael
Published: (2012-03-01)

Extrapancreatic actions of incretin-based therapies on bone in diabetes mellitus
by: Mansur, Sity Aishah
Published: (2015)

Incretins role in Latent autoimmune diabetes of adults pathogenesis, the possibility of therapy with combination of glucagon-like peptide-1 agonist (GLP-1) and insulin.
by: Iuliia V. Silko, et al.
Published: (2016-07-01)

Aqueous Extract of Nypa fruticansWurmb. Vinegar Alleviates Postprandial Hyperglycemia in Normoglycemic Rats
by: Yusoff, Nor Adlin, et al.
Published: (2015)

Oral administration of linoleic acid immediately before glucose load ameliorates postprandial hyperglycemia
by: Yuta Yamamoto, et al.
Published: (2023-07-01)

Inhibitory Effect of Jeju Tea Extracts and Vanadate on Postprandial Hyperglycemia and Hypertension, and In Vitro Study
by: Shin Young Park
Published: (2020-12-01)

Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes.
by: Feinglos, M, et al.
Published: (1997)

Role of Incretin Axis in Inflammatory Bowel Disease
by: Lihua Duan, et al.
Published: (2017-12-01)

Relationship of glycated hemoglobin, and fasting and postprandial hyperglycemia in type 2 diabetes mellitus patients in Malaysia
by: Lim, L.L., et al.
Published: (2016)

Expert committee on introduction of incretin-based therapy in Russia: advance and failure
by: Editorial team Diabetes Mellitus
Published: (2012-09-01)

Next Step in Incretin-Based Therapy: From Single to Dual Agonism
by: Subhodip Pramanik, et al.
Published: (2022-07-01)

Exposure–Response Analysis of Cardiovascular Outcome Trials With Incretin-Based Therapies
by: Qi Pan, et al.
Published: (2022-05-01)

Role of fasting duration and weekday in incretin and glucose regulation
by: Kim K B Clemmensen, et al.
Published: (2020-04-01)

Lecithin Inclusion by α-Cyclodextrin Activates SREBP2 Signaling in the Gut and Ameliorates Postprandial Hyperglycemia
by: Eunyoung Lee, et al.
Published: (2021-10-01)

Lower Glucose Effectiveness Is Associated with Postprandial Hyperglycemia in Obese/Overweight Men, Independently of Insulin Secretion
by: Ichiro Kishimoto, et al.
Published: (2022-10-01)